Products & ReviewLife Sciences

Lapatinib​

Tyrosine kinase inhibitor; Inhibits EGFR and HER2

STEMCELL Technologies Inc.

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Write your own review

Lapatinib is a selective dual inhibitor of epidermal growth factor receptor (EGFR, ERBB1) and human epidermal growth factor receptor 2 (HER2, ERBB2), each with an IC₅₀ of about 10 nM (Rusnak et al.). It binds reversibly, but with a very slow off-rate, to the ATP binding pocket in an inactive-like conformation, thus preventing autophosphorylation. Binding is very potent, with Ki values of 3 and 13 nM to EGFR and HER2 respectively (Wood et al.).

CANCER RESEARCH

  • Induces apoptosis in cells overexpressing EGFR and/or HER2, and inhibits tumor growth in a mouse xenograft model (Xia et al.).

Product Overview

Links